Vincenzo Zammuto

Dr. Vincenzo Zammuto

Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Messina, Italy
+1
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
MCMaria Teresa Caccamo
Maria Teresa Caccamo
Concetta GugliandoloConcetta Gugliandolo
Concetta Gugliandolo
Vincenzo ZammutoVincenzo Zammuto
Vincenzo Zammuto
SMSalvatore Magazù
Salvatore Magazù

7 July 2019 in Polymers
Verified
Journal Article
Open access
PDF file
Angela ScalaAngela Scala
Angela Scala
Anna PipernoAnna Piperno
Anna Piperno
AHAlexandru-Milentie Hada
Alexandru-Milentie Hada
SASimion Astilean
Simion Astilean
AVAdriana Vulpoi-Lazar
Adriana Vulpoi-Lazar
Concetta GugliandoloConcetta Gugliandolo
Concetta Gugliandolo
A straightforward and green method for the synthesis of gold, silver, and silver chloride nanoparticles (Au NPs and Ag/AgCl NPs) was developed using three different microbial exopolymers (EP) as reducing and stabilizing agents. The exopolysaccharides EPS B3-15 and EPS T14 and the poly-γ-glutamic acid γ-PGA-APA were produced by thermophilic bacteria isolated from shallow hydrothermal vents off the Eolian Islands (Italy) in the Mediterranean Sea. The production of metal NPs was monitored by UV−Vis measurements by the typical plasmon resonance absorption peak and their antimicrobial activity towards Gram-positive and Gram- negative bacteria (Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa), as well as fungi (Candida albicans) was investigated. The biological evaluation showed no activity for EP-Au NPs, except against E. coli, whereas EP-Ag NPs exhibited a broad-spectrum of activity. The chemical composition, morphology, and size of EP-Ag NPs were investigated by UV–Vis, zeta potential (ζ), dynamic light scattering (DLS) measurements and transmission electron microscopy (TEM). The best antimicrobial results were obtained for EPS B3-15-Ag NPs and EPS T14-Ag NPs (Minimum Inhibitory Concentration, MIC: 9.37–45 µg/mL; Minimum Bactericidal Concentration/Minimum Fungicidal Concentration, MBC/MFC: 11.25–75 µg/mL).

30 December 2017 in Journal of Pure and Applied Microbiology
Verified
Journal Article
Open access
CRCarmen Rizzo
Carmen Rizzo
GGGiuseppa Genovese
Giuseppa Genovese
MMMarina Morabito
Marina Morabito
CFCaterina Faggio
Caterina Faggio
MPMaria Pagano
Maria Pagano
Concetta GugliandoloConcetta Gugliandolo
Concetta Gugliandolo

20 July 2023 in Microorganisms
Verified
Journal Article
Open access
PDF file
Vincenzo ZammutoVincenzo Zammuto
Vincenzo Zammuto
Maria Giovanna RizzoMaria Giovanna Rizzo
Maria Giovanna Rizzo
CPClaudia De Pasquale
Claudia De Pasquale
GFGuido Ferlazzo
Guido Ferlazzo
Maria Teresa CaccamoMaria Teresa Caccamo
Maria Teresa Caccamo
Concetta GugliandoloConcetta Gugliandolo
Concetta Gugliandolo
We report the ability of the crude biosurfactant (BS B3-15), produced by the marine, thermotolerant Bacillus licheniformis B3-15, to hinder the adhesion and biofilm formation of Pseudomonas aeruginosa ATCC 27853 and Staphylococcus aureus ATCC 29213 to polystyrene and human cells. First, we attempted to increase the BS yield, optimizing the culture conditions, and evaluated the surface-active properties of cell-free supernatants. Under phosphate deprivation (0.06 mM) and 5% saccharose, the yield of BS (1.5 g/L) increased by 37%, which could be explained by the earlier (12 h) increase in lchAA expression compared to the non-optimized condition (48 h). Without exerting any anti-bacterial activity, BS (300 µg/mL) prevented the adhesion of P. aeruginosa and S. aureus to polystyrene (47% and 36%, respectively) and disrupted the preformed biofilms, being more efficient against S. aureus (47%) than P. aeruginosa (26%). When added to human cells, the BS reduced the adhesion of P. aeruginosa and S. aureus (10× and 100,000× CFU/mL, respectively) without altering the epithelial cells’ viability. As it is not cytotoxic, BS B3-15 could be useful to prevent or remove bacterial biofilms in several medical and non-medical applications.

20 May 2023 in Marine Drugs
Verified
Journal Article
Open access
PDF file
Vincenzo ZammutoVincenzo Zammuto
Vincenzo Zammuto
ASAntonio Spanò
Antonio Spanò
EAEleonora Agostino
Eleonora Agostino
AMAngela Macri'
Angela Macri'
CPClaudia De Pasquale
Claudia De Pasquale
Concetta GugliandoloConcetta Gugliandolo
Concetta Gugliandolo
The eradication of bacterial biofilm represents a crucial strategy to prevent a clinical problem associated with microbial persistent infection. In this study we evaluated the ability of the exopolysaccharide (EPS) B3-15, produced by the marine Bacillus licheniformis B3-15, to prevent the adhesion and biofilm formation of Pseudomonas aeruginosa ATCC 27853 and Staphylococcus aureus ATCC 29213 on polystyrene and polyvinyl chloride surfaces. The EPS was added at different times (0, 2, 4 and 8 h), corresponding to the initial, reversible and irreversible attachment, and after the biofilm development (24 or 48 h). The EPS (300 µg/mL) impaired the initial phase, preventing bacterial adhesion even when added after 2 h of incubation, but had no effects on mature biofilms. Without exerting any antibiotic activity, the antibiofilm mechanisms of the EPS were related to the modification of the (i) abiotic surface properties, (ii) cell-surface charges and hydrophobicity, and iii) cell-to-cell aggregation. The addition of EPS downregulated the expression of genes (lecA and pslA of P. aeruginosa and clfA of S. aureus) involved in the bacterial adhesion. Moreover, the EPS reduced the adhesion of P. aeruginosa (five logs-scale) and S. aureus (one log) on human nasal epithelial cells. The EPS could represent a promising tool for the prevention of biofilm-related infections.

Verified
Journal Article
Open access
PDF file
Carmen RizzoCarmen Rizzo
Carmen Rizzo
Vincenzo ZammutoVincenzo Zammuto
Vincenzo Zammuto
Angelina Lo GiudiceAngelina Lo Giudice
Angelina Lo Giudice
Maria Giovanna RizzoMaria Giovanna Rizzo
Maria Giovanna Rizzo
ASAntonio Spanò
Antonio Spanò
Concetta GugliandoloConcetta Gugliandolo
Concetta Gugliandolo
Bioprospecting in unusual marine environments provides an innovative approach to search novel biomolecules with antibiofilm activity. Antarctic sponge-associated bacteria belonging to Colwellia, Pseudoalteromonas, Shewanella and Winogradskyella genera were evaluated for their ability to contrast the biofilm formation by Pseudomonas aeruginosa ATCC 27853 and Staphylococcus aureus ATCC 29213, as model organisms. All strains were able to produce biofilm at both 4 and 25 °C, with the highest production being for Colwellia, Shewanella and Winogradskyella strains at 4 °C after 24 h. Antibiofilm activity of cell-free supernatants (CFSs) differed among strains and on the basis of their incubation temperature (CFSs4°C and CFSs25°C). The major activity was observed by CFSs4°C against S. aureus and CFSs25°C against P. aeruginosa, without demonstrating a bactericidal effect on their growth. Furthermore, the antibiofilm activity of crude extracts from Colwellia sp. GW185, Shewanella sp. CAL606, and Winogradskyella sp. CAL396 was also evaluated and visualized by confocal laser scanning microscopic images. Results based on the surface-coating assay and surface tension measurements suggest that CFSs and the crude extracts may act as biosurfactants inhibiting the first adhesion of P. aeruginosa and S. aureus. The CFSs and the novel biopolymers may be useful in applicative perspectives for pharmaceutical and environmental purposes.